Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression

doi:10.1007/s13238-016-0261-x

Protein Cell

2016, Vol. 7

Issue (6) : 445-449 https://doi.org/10.1007/s13238-016-0261-x

LETTER

Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression

Chuu-Yun A. Wong¹,Haihong Jiang¹,Peter W. Abel¹,Margaret A. Scofield¹,Yan Xie¹,Taotao Wei^2,^*(

),Yaping Tu^1,^*(

)

¹. Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178, USA
². National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

Download: PDF(680 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Corresponding Author(s): Taotao Wei,Yaping Tu

Issue Date: 20 June 2016

Cite this article:

Chuu-Yun A. Wong,Haihong Jiang,Peter W. Abel, et al. Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression[J]. Protein Cell, 2016, 7(6): 445-449.

URL:

https://academic.hep.com.cn/pac/EN/10.1007/s13238-016-0261-x
https://academic.hep.com.cn/pac/EN/Y2016/V7/I6/445

1	Barboule N, Lafon C, Chadebech P, Vidal S, Valette A (1999) Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett 444:32–37 https://doi.org/10.1016/S0014-5793(99)00022-8
2	Fortino V, Torricelli C, Capurro E, Sacchi G, Valacchi G, Maioli E (2008) Antiproliferative and survival properties of PMA in MCF-7 breast cancer cell. Cancer Invest 26:13–21 https://doi.org/10.1080/07357900701637949
3	Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev 7:281–294 https://doi.org/10.1038/nrc2110
4	Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5:341–354 https://doi.org/10.1038/nrc1609
5	Knight-Krajewski S, Welsh CF, Liu Y, Lyons LS, Faysal JM, Yang ES, Burnstein KL (2004) Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21 (CIP1) levels in androgen-independent human prostate cancer cells. Oncogene 23:5513–5522 https://doi.org/10.1038/sj.onc.1207708
6	Montero JC, Seoane S, Ocaña A, Pandiella A(2011) P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer. Oncogene 30:1059–1071 https://doi.org/10.1038/onc.2010.489
7	Montero JC, Seoane S, Pandiella A (2013) Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells. Cell Signal 25:2281–2289 https://doi.org/10.1016/j.cellsig.2013.07.018
8	Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD (2005) Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res 65:8366–8371 https://doi.org/10.1158/0008-5472.CAN-05-0553
9	Qin J, Xie Y, Wang B, Hoshino M, Wolff DW, Zhao J, Scofield MA, Dowd FJ, Lin MF, Tu Y (2009) Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene 28:1853–1863 https://doi.org/10.1038/onc.2009.30
10	Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013–3020 https://doi.org/10.1038/sj.onc.1203621
11	Smith M, Procter RD, Gelber S, Guillaume A, Feyereislova M, Dowsett A, Goldhirsch M, Untch G, Mariani J, Baselga J (2007) 2-year follow-up of trastuzumab after adjuvant chemother-apy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369:29–36 https://doi.org/10.1016/S0140-6736(07)60028-2
12	Sosa MS, Lopez-Haber C, Yang C, Wang H, Lemmon MA, Busillo JM, Luo J, Benovic JL, Klein-Szanto A, Yagi H (2010) Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell 40:877–892 https://doi.org/10.1016/j.molcel.2010.11.029
13	Urtreger AJ, Kazanietz MG, de Kier Bal, Joffé ED (2012) Contribu-tion of individual PKC isoforms to breast cancer progression. IUBMB Life 64:18–26 https://doi.org/10.1002/iub.574
14	Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdjument-Bromage H, Tempst P, Hawkins PT, Stephens LR (2002) P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 108:809–821 https://doi.org/10.1016/S0092-8674(02)00663-3
15	Zhao Y, Wang Z, Jiang Y, Yang C (2011) Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells. Cancer Lett 313:54–63 https://doi.org/10.1016/j.canlet.2011.08.023

[1]

PAC-0445-15202-TYP_suppl_1

Download

Viewed

Full text

Abstract

Cited

Shared

Discussed